Showing results (331-340 of 386) with videos related to
Sort By:
Pageof 39
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 19, 2022
3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohortO Godin, B Pignon, A Szoke, et al.Journal of Affective Disorders|October 12, 2014
Risk factors for treatment resistance in unipolar depression: a systematic reviewD Bennabi, B Aouizerate, W El-Hage, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 23, 2023
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohortN Vidal, E Brunet-Gouet, S Frileux, et al.Acta Psychiatrica Scandinavica|August 17, 2019
Cerebellar parcellation in schizophrenia and bipolar disorderC Laidi, T Hajek, F Spaniel, et al.Molecular Psychiatry|March 2, 2011
Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorderL Priebe, F A Degenhardt, S Herms, et al.Journal of Affective Disorders|November 15, 2018
Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohortG Fond, O Godin, F Schürhoff, et al.Molecular Psychiatry|May 17, 2007
Abnormal melatonin synthesis in autism spectrum disordersJ Melke, H Goubran Botros, P Chaste, et al.Methods of Information in Medicine|March 20, 2013
Discussion of "Attitude of physicians towards automatic alerting in computerized physician order entry systems"D W Bates, M T Baysari, M Dugas, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 16, 2018
Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohortG Fond, E Bulzacka, M Boucekine, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 25, 2019
Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohortG Fond, O Godin, M Dumontaud, et al.Pageof 39